RE:RE:Seems LikeIMO the problem is Canada, period. The culture, the poor regulatory environment.
IT has always been too adverse to bussiness as usual and blunt instruments of revenue. Different, innovative, new things don't get financed. If they're not another mine or oil, nobody's interested. I see interesting new ideas and approaches languish all the time on the TSXV and CSE.
If there are any financers who do approach, usually they attach predatorial strings that more or less let them seize the company and/or screw over the other shareholders. Bombs of cheap shares hidden in the fine print of finance agreements, though sometimes other things.
Or in many cases the CEOs live on entitled salaries of $300k+/yr with options or share rights when their company has little to no revenue and hasn't for years. Because the CEOs pocket so much a new financing from said unsavory figures is always around a corner. The rich get richer and fail upwards.
Canada's microcaps have developed an infamous reputation around the world due to all of this. The germans wised up to it years ago (link):
ATTENTION! Warning about penny stock scams! | stock3 When Canada says "oh no!" because even though it had four years to realize America was not a reliable trading partner yet did nothing, it doesn't surprise me one bit. Canada is mostly run by exploiters who are happy to do "business as usual" until the well runs dry.
The idea of actually developing new ideas, new IP that add value to resource and exporting them around the world is mostly shunned for whatever the easiest and already developed answer is.
If you ask me --- in my opinion --- all of this is part of why Willow Biosciences is announcing they hit the iceberg today.